Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Pramipexole for Treatment-Resistant Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets diagnostic criteria for major depressive disorder~* Meets criteria for current major depressive episode~* Score of at least 18 on the Montgomery-Asberg Depression Rating Scale (MADRS) at the baseline visit~* Currently being treated with antidepressant monotherapy at an adequate dose for 6 weeks or willing to enter open lead-in treatment~* Agrees to use an effective form of contraception throughout the study~Exclusion Criteria:~* Pregnant~* At risk for suicide or homicide~* Unstable medical illness (e.g., cardiovascular, liver, kidney, respiratory, endocrine, or neurologic disease, including uncontrolled seizure disorder)~* History of a substance use disorder within 6 months of study enrollment~* History of or current psychotic features~* Currently being treated with typical or atypical antipsychotic medications~* Currently being treated with a medication known to significantly decrease pramipexole clearance (e.g., cimetidine, ranitidine, diltazem, verapamil, quinine or triamterene)~* Clinical or laboratory evidence of untreated hypothyroidism~* History of a 2-week or longer course of pramipexole~* Intolerance of pramipexole at any dose~* Any investigational psychotropic drug use within the last three months~* Level 3 or greater antidepressant resistance as assessed by the ATHF~* Three or more episodes of self-harm in the year prior to study enrollment~* Documented history of poor treatment adherence or frequently missed appointments~* Parkinson's disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Sugar pill (Type: PLACEBO_COMPARATOR): Placebo
- Pramipexole (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).